• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物补片用于清洁-污染和污染性腹疝修补术中腹壁重建的疗效分析

Outcomes Analysis of Biologic Mesh Use for Abdominal Wall Reconstruction in Clean-Contaminated and Contaminated Ventral Hernia Repair.

作者信息

Sbitany Hani, Kwon Edwin, Chern Hueylan, Finlayson Emily, Varma Madhulika G, Hansen Scott L

机构信息

From the Divisions of *Plastic and Reconstructive Surgery, and †Colorectal Surgery, University of California, San Francisco, San Francisco, CA.

出版信息

Ann Plast Surg. 2015 Aug;75(2):201-4. doi: 10.1097/SAP.0000000000000030.

DOI:10.1097/SAP.0000000000000030
PMID:24317239
Abstract

BACKGROUND

Repair of grade 3 and grade 4 ventral hernias is a distinct challenge, given the potential for infection, and the comorbid nature of the patient population. This study evaluates our institutional outcomes when performing single-stage repair of these hernias, with biologic mesh for abdominal wall reinforcement.

METHODS

A prospectively maintained database was reviewed for all patients undergoing repair of grade 3 (potentially contaminated) or grade 4 (infected) hernias, as classified by the Ventral Hernia Working Group. All those patients undergoing repair with component separation techniques and biologic mesh reinforcement were included. Patient demographics, comorbidities, and postoperative complications were analyzed. Univariate analysis was performed to define factors predictive of hernia recurrence and wound complications.

RESULTS

A total of 41 patients underwent single-stage repair of grade 3 and grade 4 hernias during a 4-year period. The overall postoperative wound infection rate was 15%, and hernia recurrence rate was 12%. Almost all recurrences were seen in grade 4 hernia repairs, and in those patients undergoing bridging repair of the hernia. One patient required removal of the biologic mesh. Those factors predicting hernia recurrence were smoking (P = 0.023), increasing body mass index (P = 0.012), increasing defect size (P = 0.010), and bridging repair (P = 0.042). No mesh was removed due to perioperative infection. Mean follow-up time for this patient population was 25 months.

CONCLUSIONS

Single-stage repair of grade 3 hernias performed with component separation and biologic mesh reinforcement is effective and offers a low recurrence rate. Furthermore, the use of biologic mesh allows for avoidance of mesh explantation in instances of wound breakdown or infection. Bridging repairs are associated with a high recurrence rate, as is single-stage repair of grade 4 hernias.

摘要

背景

鉴于存在感染风险以及患者群体的共病性质,3级和4级腹疝的修复是一项独特的挑战。本研究评估了我们机构在使用生物补片进行腹壁加强的情况下对这些疝进行一期修复的效果。

方法

回顾前瞻性维护的数据库,纳入所有接受腹疝工作组分类为3级(潜在污染)或4级(感染)疝修补术的患者。所有采用组织分离技术和生物补片加强修补的患者均纳入研究。分析患者的人口统计学特征、共病情况和术后并发症。进行单因素分析以确定预测疝复发和伤口并发症的因素。

结果

在4年期间,共有41例患者接受了3级和4级疝的一期修复。术后总体伤口感染率为15%,疝复发率为12%。几乎所有复发都见于4级疝修补术以及采用疝桥接修补术的患者。1例患者需要取出生物补片。预测疝复发的因素包括吸烟(P = 0.023)、体重指数增加(P = 0.012)、缺损尺寸增大(P = 0.010)和桥接修补(P = 0.042)。没有因围手术期感染而取出补片。该患者群体的平均随访时间为25个月。

结论

采用组织分离和生物补片加强进行3级疝的一期修复是有效的,且复发率低。此外,使用生物补片可避免在伤口裂开或感染时取出补片。桥接修补术与高复发率相关,4级疝的一期修复也是如此。

相似文献

1
Outcomes Analysis of Biologic Mesh Use for Abdominal Wall Reconstruction in Clean-Contaminated and Contaminated Ventral Hernia Repair.生物补片用于清洁-污染和污染性腹疝修补术中腹壁重建的疗效分析
Ann Plast Surg. 2015 Aug;75(2):201-4. doi: 10.1097/SAP.0000000000000030.
2
A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh.利用生物补片进行一期修复感染和污染的腹壁缺损的 5 年临床经验。
Ann Surg. 2013 Jun;257(6):991-6. doi: 10.1097/SLA.0b013e3182849871.
3
Comparative study between biologic porcine dermal meshes: risk factors of postoperative morbidity and recurrence.生物猪真皮网片的比较研究:术后发病和复发的危险因素
J Wound Care. 2016 Jun;25(6):320-5. doi: 10.12968/jowc.2016.25.6.320.
4
Primary fascial closure with biologic mesh reinforcement results in lesser complication and recurrence rates than bridged biologic mesh repair for abdominal wall reconstruction: A propensity score analysis.与桥接生物补片修复腹壁重建相比,采用生物补片加强的一期筋膜闭合术并发症和复发率更低:一项倾向评分分析。
Surgery. 2017 Feb;161(2):499-508. doi: 10.1016/j.surg.2016.08.009. Epub 2016 Oct 31.
5
Outcomes of abdominal wall reconstruction with acellular dermal matrix are not affected by wound contamination.使用脱细胞真皮基质进行腹壁重建的结果不受伤口污染的影响。
J Am Coll Surg. 2014 Nov;219(5):853-64. doi: 10.1016/j.jamcollsurg.2014.06.021. Epub 2014 Jul 5.
6
Suture, synthetic, or biologic in contaminated ventral hernia repair.在污染性腹疝修补术中使用的合成或生物缝线。
J Surg Res. 2016 Feb;200(2):488-94. doi: 10.1016/j.jss.2015.09.007. Epub 2015 Sep 9.
7
Indications and outcomes following complex abdominal reconstruction with component separation combined with porcine acellular dermal matrix reinforcement.复杂腹壁重建联合成分离术及猪脱细胞真皮基质强化后的适应证及治疗结果
Ann Plast Surg. 2012 Oct;69(4):394-8. doi: 10.1097/SAP.0b013e31822f997b.
8
Assessing complications and cost-utilization in ventral hernia repair utilizing biologic mesh in a bridged underlay technique.评估在桥接衬垫技术中使用生物补片进行腹疝修补术的并发症及成本效益。
Am J Surg. 2015 Apr;209(4):695-702. doi: 10.1016/j.amjsurg.2014.04.017. Epub 2014 Jul 11.
9
Outcomes with porcine acellular dermal matrix versus synthetic mesh and suture in complicated open ventral hernia repair.猪脱细胞真皮基质与合成补片及缝线用于复杂开放性腹疝修补术的疗效比较
Surg Infect (Larchmt). 2014 Oct;15(5):506-12. doi: 10.1089/sur.2013.090. Epub 2014 Sep 12.
10
Complex abdominal wall reconstruction: an outcomes review.复杂腹壁重建:结果回顾
Ann Plast Surg. 2013 Sep;71(3):266-8. doi: 10.1097/SAP.0b013e31828a49f9.

引用本文的文献

1
Acellular dermal matrices in reconstructive surgery; history, current implications and future perspectives for surgeons.重建手术中的脱细胞真皮基质:外科医生的历史、当前影响及未来展望
World J Clin Cases. 2024 Dec 16;12(35):6791-6807. doi: 10.12998/wjcc.v12.i35.6791.
2
Slowly absorbable mesh versus standard care in the management of contaminated midline incisional hernia (COMpACT-BIO): a multicentre randomised controlled phase III trial including a health economic evaluation.慢吸收网片与标准治疗在污染的中线切口疝治疗中的比较(COMpACT-BIO):一项包含卫生经济学评价的多中心随机对照 III 期临床试验。
BMJ Open. 2022 Aug 25;12(8):e061184. doi: 10.1136/bmjopen-2022-061184.
3
Surgical site infection in mesh repair for ventral hernia in contaminated field: A systematic review and meta-analysis.
污染区域腹疝补片修补术的手术部位感染:一项系统评价和荟萃分析。
Ann Med Surg (Lond). 2021 Feb 12;63:102173. doi: 10.1016/j.amsu.2021.02.019. eCollection 2021 Mar.
4
Risk factors, outcomes, and complications associated with combined ventral hernia and enterocutaneous fistula single-staged abdominal wall reconstruction.与联合腹疝和肠皮肤瘘单阶段腹壁重建相关的风险因素、结果和并发症。
Hernia. 2021 Dec;25(6):1537-1548. doi: 10.1007/s10029-021-02371-2. Epub 2021 Feb 4.
5
Decellularization and In Vivo Recellularization of Abdominal Porcine Fascial Tissue.去细胞化及腹腔猪筋膜组织的体内再细胞化。
Tissue Eng Regen Med. 2021 Jun;18(3):369-376. doi: 10.1007/s13770-020-00314-z. Epub 2020 Nov 24.
6
Long-term outcomes after contaminated complex abdominal wall reconstruction.污染性复杂腹壁重建术后的长期结果。
Hernia. 2020 Jun;24(3):459-468. doi: 10.1007/s10029-020-02124-7. Epub 2020 Feb 20.
7
Acellular Dermal Matrices: Applications in Plastic Surgery.脱细胞真皮基质:在整形外科中的应用。
Semin Plast Surg. 2019 Aug;33(3):173-184. doi: 10.1055/s-0039-1693019. Epub 2019 Aug 2.
8
Absorbable Polyglactin vs. Non-Cross-linked Porcine Biological Mesh for the Surgical Treatment of Infected Incisional Hernia.可吸收聚甘醇酸与非交联猪源性生物补片在感染性切口疝手术治疗中的应用比较。
J Gastrointest Surg. 2020 Feb;24(2):435-443. doi: 10.1007/s11605-018-04095-8. Epub 2019 Jan 22.
9
Systematic review of the stage of innovation of biological mesh for complex or contaminated abdominal wall closure.生物补片用于复杂或污染腹壁闭合创新阶段的系统评价
BJS Open. 2018 Jun 14;2(6):371-380. doi: 10.1002/bjs5.78. eCollection 2018 Dec.
10
Soft Tissue Repair with Easy-Accessible Autologous Newborn Placenta or Umbilical Cord Blood in Severe Malformations: A Primary Evaluation.严重畸形中使用易于获取的自体新生儿胎盘或脐带血进行软组织修复:初步评估
Stem Cells Int. 2017;2017:1626741. doi: 10.1155/2017/1626741. Epub 2017 Dec 17.